RBM10 and lung adenocarcinoma: From left to right, we found that, with the decrease in RBM10 expression, the prognostic risk coefficient of lung adenocarcinoma patients also increased, and deaths were concentrated in the high-risk population area on the right, which also proved that its prognostic correlation with low expression of RBM10 may be associated with the prognostic risk and high mortality of lung adenocarcinoma (Figure 8).